• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. G7 VIT E NEUTRAL LNR 36MM G; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. G7 VIT E NEUTRAL LNR 36MM G; PROSTHESIS, HIP Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Myocardial Infarction (1969)
Event Date 05/23/2022
Event Type  Injury  
Event Description
It was reported that a clinical study patient underwent a left total hip arthroplasty.Subsequently, the patient experienced a myocardial infarction 14 days postop.Patient had 4 stents placed.Attempts have been made and no further information has been provided.
 
Manufacturer Narrative
(b)(4).D10: cat# 650-0661, lot# 3107661,delta ceramic fem hd 36/0mm.Cat# 010000666, lot# 7128460, g7 pps ltd acet shell 58g.Cat# 51-104180, lot# 6966785, tprlc 133 t1 pps ho 18x156mm.G2: foreign: netherlands.The customer has indicated that the product will not be returned to zimmer biomet for investigation as it remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Manufacturer Narrative
This follow-up report is being submitted to relay additional information.Procedural related complications are influenced by the type of surgery, patients pre-existing comorbidities, and perioperative management.Side effects of the administration of anesthesia are a known cause of chest pain, ekg changes, and myocardial infarction (heart attack) during the intraoperative and postoperative recovery.Elective total joint patients typically have a cardiac workup prior to surgery to assess the patient¿s physical readiness for surgery, hence reducing their risk for these cardiac related complications.Patients are at the highest risk immediately post op but continue to be at risk for several weeks after the procedure.As the reported complaint indicated, a cardiac postoperative complication developed two weeks postop, necessitating medical treatment to preclude further deterioration.The medical records also indicate that four cardiac stents were required which are placed due to narrowing of the vessels to treat atherosclerosis or plaque build up in the vessels which cause the narrowing and indicate underlying comorbidities prior to the procedure.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
No further information at the time of this report.
 
Manufacturer Narrative
This follow-up report is being submitted to relay additional information.
 
Event Description
It was reported that a clinical study patient underwent a left total hip arthroplasty.Subsequently, the patient experienced a myocardial infarction 14 days postop and underwent angioplasty with placement of 4 cardiac stents.At the next follow up two days later, the patient was doing well with no further cardiac complications.There is no additional information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G7 VIT E NEUTRAL LNR 36MM G
Type of Device
PROSTHESIS, HIP
Manufacturer (Section D)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer (Section G)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key17171929
MDR Text Key317632546
Report Number0001822565-2023-01575
Device Sequence Number1
Product Code LPH
UDI-Device Identifier00889024519923
UDI-Public(01)00889024519923(17)260927(10)65224087
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K190660
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 06/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number30103607
Device Lot Number65224087
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
Treatment
SEE H10 NARRATIVE.
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
Patient SexFemale
Patient Weight88 KG
-
-